The sequence-activity relationship between metallo-β-lactamases IMP-1, IMP-6, and IMP-25 suggests an evolutionary

Eleanor M Liu1, Kevin M Pegg, Peter Oelschlaeger

  • 1Department of Pharmaceutical Sciences, Western University of Health Sciences, Pomona, CA, USA.

Insights

Metallo-β-lactamases (MBLs) confer antibacterial resistance. IMP-1 is broadly active, while IMP-6 and IMP-25 specifically target meropenem, potentially due to a G235S mutation influencing enzyme activity.

Area of Science:

  • Microbiology
  • Biochemistry
  • Structural Biology

Background:

  • Metallo-β-lactamases (MBLs) are critical enzymes mediating bacterial resistance to β-lactam antibiotics.
  • Understanding the structure-activity relationships of MBLs is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the sequence-activity relationship among closely related MBLs: IMP-1, IMP-6, and IMP-25.
  • To elucidate the molecular basis for differential substrate specificities, particularly concerning carbapenem inactivation.

Main Methods:

  • Enzyme activity assays across a spectrum of β-lactam antibiotics.
  • Molecular modeling to analyze structural differences and their potential impact on enzyme function.

Main Results:

  • IMP-1 exhibits broader activity against various β-lactam agents.
  • IMP-6 and IMP-25 demonstrate enhanced specificity for inactivating the carbapenem meropenem.
  • Molecular modeling suggests the G235S mutation in IMP-25 influences activity, potentially through interactions with Asn233.

Conclusions:

  • IMP-1, IMP-6, and IMP-25 display distinct substrate profiles, highlighting evolutionary divergence in MBLs.
  • The G235S mutation is a key factor in the carbapenem-specific activity of IMP-25.
  • These findings provide insights into MBL resistance mechanisms and potential targets for antimicrobial drug development.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...